Severe Community-Acquired Pneumonia with Disseminated Infection Caused by Highly Virulent Pseudomonas aeruginosa: Successful Treatment of a Case

由高毒力铜绿假单胞菌引起的重症社区获得性肺炎伴播散性感染:一例成功治疗病例

阅读:1

Abstract

PURPOSE: Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative pathogen with strong colonization ability and multidrug resistance. Disseminated infection complicated by secondary organizing pneumonia is extremely uncommon. PATIENTS AND METHODS: We describe a rare case of severe community-acquired pneumonia due to highly virulent P. aeruginosa, complicated by endophthalmitis, ecthyma gangrenosum, and secondary organizing pneumonia. Clinical features, microbiological results, histopathology, and treatment were analyzed. RESULTS: A 61-year-old woman developed a disseminated infection caused by highly virulent P. aeruginosa, presenting with persistent high fever, impaired consciousness, ocular involvement, mucocutaneous erosions, and widespread erythematous papules. The diagnosis was confirmed by consistent isolation of P. aeruginosa from sputum, blood, and ocular pus, and detection in bronchoalveolar lavage fluid by metagenomic sequencing. Whole-genome sequencing of the ocular isolate identified multiple virulence factors, including Type III secretion system effectors ExoS, ExoT, and ExoY, reflecting the pathogen's capacity for systemic dissemination. Lung biopsy revealed extensive necrosis with fibrinoid exudation and granulation tissue, consistent with secondary organizing pneumonia. The patient received combined antimicrobial and anti-inflammatory therapy targeting both the disseminated infection and the organizing pneumonia, resulting in rapid defervescence, restoration of consciousness and oral intake, and clinical improvement. She was subsequently discharged in stable condition. CONCLUSION: This case highlights the disseminated potential of highly virulent P. aeruginosa and underscores the need for vigilance regarding secondary organizing pneumonia in such infections. Timely recognition, together with a treatment strategy combining appropriate antimicrobial and anti-inflammatory therapy, is crucial to improving patient outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。